Skip to Main Content

MGP Ingredients, Inc. (NASDAQ: MGPI) Securities Fraud Investigation

On October 17, 2024, MGP Ingredients revised its full year 2024 guidance and released its preliminary financial results for the third quarter ended September 30, 2024. In the results, MGP Ingredients revealed that the company expects declines in sales, adjusted net income, and adjusted EBITDA compared to the third quarter of 2023, and that the company “now expects financial results to be below the expectations confirmed during its second quarter conference call held on August 1, 2024.” 

On this news, the price of MGP shares declined by $19.71, or approximately 24.16%, from $81.57 per share on October 17, 2024, to close at $61.86 per share on October 18, 2024.

If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP:  Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.  

Complete this form with your transactions in MGP Ingredients, Inc. 
 securities between February 22, 2024 and October 17, 2024.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of MGP Ingredients, Inc. prior to the Class Period?
Are you a current or former employee of MGP Ingredients, Inc. ?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email